Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 26754771)

Published in Nat Commun on January 12, 2016

Authors

Tania M Puvirajesinghe1,2,3,4, François Bertucci2,3,4,5, Ashish Jain6,7, Pierluigi Scerbo8, Edwige Belotti1,2,3,4, Stéphane Audebert2,3,4,9, Michael Sebbagh1,2,3,4, Marc Lopez2,3,4,5, Andreas Brech7, Pascal Finetti2,3,4,5, Emmanuelle Charafe-Jauffret2,3,4,5, Max Chaffanet2,3,4,5, Rémy Castellano2,3,4,10, Audrey Restouin2,3,4,10, Sylvie Marchetto1,2,3,4, Yves Collette2,3,4,10, Anthony Gonçalvès1,2,3,4,9, Ian Macara11, Daniel Birnbaum2,3,4,5, Laurent Kodjabachian8, Terje Johansen6, Jean-Paul Borg1,2,3,4,9

Author Affiliations

1: CRCM, Cell Polarity, Cell signalling and Cancer 'Equipe labellisée Ligue Contre le Cancer', Inserm, U1068, Marseille F-13009, France.
2: Institut Paoli-Calmettes, Marseille F-13009, France.
3: Aix-Marseille Université, Marseille F-13284, France.
4: CNRS, UMR725, Marseille F-13009, France.
5: CRCM, Molecular Oncology 'Equipe labellisée Ligue Contre le Cancer', Inserm, U1068, Marseille F-13009, France.
6: Molecular Cancer Research Group, Department of Medical Biology, University of Tromsø-The Arctic University of Norway, Tromsø 9037, Norway.
7: Department of Molecular Cell Biology, Centre for Cancer Biomedicine, University of Oslo and Institute for Cancer Research, The Norwegian Radium Hospital, Oslo N-0310, Norway.
8: Institut de Biologie du Développement de Marseille, Aix-Marseille Université, CNRS UMR 7288, Marseille F-13288, France.
9: CRCM, Marseille Proteomics Platform, Inserm, U1068, Marseille F-13009, France.
10: CRCM, TrGET Platform, Inserm, U1068, Marseille F-13009, France.
11: Department of Microbiology, University of Virginia School of Medicine, Charlottesville, Virginia, Tennessee 37240-7935, USA.

Articles cited by this

Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82

Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem (2007) 21.73

Selective autophagy mediated by autophagic adapter proteins. Autophagy (2011) 6.88

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

p62 at the crossroads of autophagy, apoptosis, and cancer. Cell (2009) 5.97

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell (2011) 5.06

Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene (2006) 4.85

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A (2000) 4.71

The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell (2008) 4.48

REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat (2006) 4.42

Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 4.29

p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell (2011) 3.46

Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet (2008) 3.43

The planar cell-polarity gene stbm regulates cell behaviour and cell fate in vertebrate embryos. Nat Cell Biol (2002) 3.13

Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair follicles. Nat Cell Biol (2008) 3.07

Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J Biol Chem (2003) 3.02

Integrated profiling of basal and luminal breast cancers. Cancer Res (2007) 2.86

Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol (1998) 2.35

The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol (2005) 2.28

Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell (2007) 2.25

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol (2010) 2.20

Mammalian Scribble forms a tight complex with the betaPIX exchange factor. Curr Biol (2004) 1.89

The planar polarity gene strabismus regulates convergent extension movements in Xenopus. EMBO J (2002) 1.76

Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK. EMBO J (2004) 1.67

Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell (2012) 1.65

The JIP family of MAPK scaffold proteins. Biochem Soc Trans (2006) 1.62

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol (1998) 1.61

The frizzled extracellular domain is a ligand for Van Gogh/Stbm during nonautonomous planar cell polarity signaling. Dev Cell (2008) 1.55

The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer (2007) 1.49

A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell (2014) 1.44

VANGL2 mutations in human cranial neural-tube defects. N Engl J Med (2010) 1.44

Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med (2012) 1.43

Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One (2011) 1.27

A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene (2011) 1.20

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res (2013) 1.14

JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol (2014) 1.11

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells. Cancer Sci (2012) 1.10

Distinct Xenopus Nodal ligands sequentially induce mesendoderm and control gastrulation movements in parallel to the Wnt/PCP pathway. Development (2010) 1.04

The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res (2013) 1.03

Vang-like protein 2 and Rac1 interact to regulate adherens junctions. J Cell Sci (2010) 1.02

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco Targets Ther (2013) 1.01

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev (2014) 1.01

The 2 Faces of JNK Signaling in Cancer. Genes Cancer (2013) 1.00

Molecular and cellular mechanisms underlying neural tube defects in the loop-tail mutant mouse. Biochemistry (2010) 0.97

Oncogenic suppression of apoptosis uncovers a Rac1/JNK proliferation pathway activated by loss of Par3. Oncogene (2014) 0.94

The human PDZome: a gateway to PSD95-Disc large-zonula occludens (PDZ)-mediated functions. Mol Cell Proteomics (2013) 0.94

Gipc1 has a dual role in Vangl2 trafficking and hair bundle integrity in the inner ear. Development (2012) 0.93

Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes. PLoS One (2012) 0.92

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer. Breast Cancer Res (2014) 0.90

Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer. Endocr Relat Cancer (2014) 0.89

Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin. J Immunol (2013) 0.89

SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors. Cell Cycle (2015) 0.87

Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells. Cell Death Dis (2014) 0.84

Insight into planar cell polarity. Exp Cell Res (2014) 0.83